The finding of abnormally high serum/plasma copper concentration in patients with rheumatoid arthritis (RA) has attracted interest. '-5 This interest has been further stimulated by the discovery that copper complexes of anti-inflammatory agents are more potent than the parent compounds.67 Furthermore, it has been claimed (though not generally accepted) that the traditional use of copper bracelets by arthritic patients results in improvement.89
On the other hand, many workers, 14-12 but not all, 3 have shown a correlation of serum copper concentration with disease activity in RA.
The purpose of the present study was to cast further light on the significance of raised serum copper in RA patients, particularly its relation to disease activity. The latter was assessed by a newly developed composite activity index (CAl). 14 I5 Serum copper was also measured in healthy controls and in patients with either osteoarthritis (OA) or ankylosing spondylitis (AS). Assessment of the overall disease activity in the RA patients was performed using a CAI, including both clinical and laboratory markers (Table 2) ,y-glutamyltransferase (GGT), erythrocyte sedimentation rate (ESR), total white blood count (WBC), haemoglobin (Hb), platelet count. Serum copper was measured by a modification of the method described by Piper and Higgins," using a double beam atomic absorption spectrophotometer (PerkinElmer model 306, Beaconsfield, Buckinghamshire). Protein free extracts were prepared by diluting serum with one volume of 200 g/l trichloroacetic acid, followed by mixing and centrifugation. The supernatants were then aspirated directly into the air-acetylene flame.
STATISTICAI ANAt YSIS
Comparison between groups was performed by MannWhitney U test (two tailed). Correlations were calculated using either Pearson's correlation coefficient (r) or Spearman's rank correlation coefficient (rs). control 21-4 ± 3-7, reference range 14-0-21-8; RA 26-9 ± 6-7, OA 20-9 ± 2-7; AS 25-6 ± 6-4.
S[-RJM COPPER IN PATIENT'S WITH RA
The serum copper level in 60 RA patients showed no correlation with either the patient's age or the duration of disease. Median serum copper concentrations in male (24-0 ,umol/l) and female (26 5 ,umol/l) patients were not significantly different.
RA patients with IgMRF+ve had a significantly higher median serum copper concentration ,umol/l) than that of patients with IgMRF-ve (23*4 ,umol/llp < 0-03).
RA patients with extra-articular manifestations had a higher median serum copper (29-0 ,umol/l) than that of patients without them ,umol/l). However, the difference was not significant.
RA patients treated with gold, penicillamine or corticosteroids had a median serum copper (25 *4 ,mol/l) not significantly different from that of those treated with non-steroidal anti-inflammatory drugs (26-2 ,umol/l). 
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The median serum copper concentration of 19 RA patients in the highly active group (30 5 ,umol/l) was significantly higher than that of RA patients in both the moderately active and the slightly active groups (p < 0 004 and p < 0 001 respectively; Fig. 2 ).
Highly significant correlation was found between serum copper value and disease activity as measured by the CAI (r = 0-48, p < 0-001; Fig. 3) .
The correlation of serum copper concentration with each individual criterion forming the CAI is given in Table 2 .
The relation between serum copper concentration and other factors believed to be related to disease activity in RA is shown in Table 3 . Discussion Our results support the previous reports of raised serum copper both in RA' -5 and in AS" -2, not related to age, disease duration or drug administration.
Most of the copper is tightly bound to a specific carrier protein caeruloplasmin. This protein is known to behave as an acute phase reactant which increases nonspecifically in response to inflammation.') Caeruloplasmin analysis was not part of the present study There is ample evidence of its strongly positive correlation with serum copper-for example, Scudder et a12 have reported r = 0-86 p < 0-001 in normals and r = 0-84 p < 0 001 in RA. This is supported by other studies in normals' '23 and in RA. 3 RA is a chronic inflammatory disease with acute exacerbations. and an increase in serum acute phase proteins. Therefore, it is likely that in our RA patients.
raised serum copper was a secondary result of high concentrations of caeruloplasmin rather than a primary disturbance of copper metabolism. This explanation is supported by our finding that the acute phase protein CRP and the ESR (which is influenced by the acute phase protein fibrinogen-4) were raised in RA patients. Both CRP and ESR correlated highly significantly with serum copper values. On the other hand, albumin, which is not an acute phase protein, was not significantly altered, and showed no relation with serum copper. Further evidence Based on the above results, a significant correlation was found between serum copper and the overall disease activity as measured by the CAI which included both laboratory and clinical markers of disease activity: patients assessed as having highly active disease showed significantly higher median serum copper values than patients with either slightly or moderately active disease. The lack of correlation between serum copper concentrations and the Al, number of tender joints and pain may reflect the fact that most of our patients were receiving treatment with non-steroidal anti-inflammatory drugs. These drugs improved joint tenderness and pain, but are thought to have little, if any, effect on the acute phase proteins. 25 Our results, therefore, suggest that serum copper might provide an additional and useful laboratory marker for the assessment of disease activity in RA.
We have shown that IgMRF was significantly correlated with serum copper and patients with IgMRF+ve exhibited significantly higher serum copper concentrations than those with IgMRF-ve. Moreover, patients with extra-articular manifestations showed a slightly but not significantly higher median serum copper concentration (29-0 ,tmol/l) than those without (24-4 ,u mol/1). The presence of both IgMRF and extra-articular features in RA are known to be associated with severe disease.26 Our finding of highly significant inverse correlation between serum copper concentrations and GS might also be considered as further evidence for the association between raised serum copper and severe disease. Weak grip is mainly the result of either highly active disease or a severely deformed hand and both are manifestations of severe RA.
Oxygen free radicals generated during phagocytosis have been suggested to be responsible for the development of many pathological lesions in RA.27-30 Furthermore, synovial fluid (SF) copper has been recently shown to correlate significantly with SF free radical oxidation products in patients with RA.3' Since copper has been shown in vitro to be a good catalyst for free radical reactions,32 the relevance of raised serum copper to the development of such lesions is of interest.
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